01 6ENTASIS THERAP
01 18658641
02 18889671
03 19040528
04 19187495
05 19540394
06 19839641
01 3Y
02 3Blank
01 6Blank
01 12029-10-13
02 12030-06-20
03 42034-01-21
Patent Expiration Date : 2034-01-21
US Patent Number : 9839641
Drug Substance Claim :
Drug Product Claim :
Application Number : 219491
Patent Use Code : U-4369
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-01-21
Patent Expiration Date : 2034-01-21
US Patent Number : 9540394
Drug Substance Claim :
Drug Product Claim :
Application Number : 219491
Patent Use Code : U-4369
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-01-21
Patent Expiration Date : 2034-01-21
US Patent Number : 9187495
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 219491
Patent Use Code : U-4369
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-01-21
Patent Expiration Date : 2029-10-13
US Patent Number : 9040528
Drug Substance Claim :
Drug Product Claim :
Application Number : 219491
Patent Use Code : U-4369
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-10-13
Patent Expiration Date : 2034-01-21
US Patent Number : 8889671
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 219491
Patent Use Code : U-4369
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-01-21
Patent Expiration Date : 2030-06-20
US Patent Number : 8658641
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 219491
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-06-20
